Johannesburg - Medi-Clinic Corporation [JSE:MDC] on Friday provided further details about its R5bn rights offer‚ announced last week.
The rights offer will consist of an offer of 174 641 984 new Mediclinic shares at an issue price of R28.63 per share in the ratio of 26.77263 new Mediclinic shares for every 100 held on the record date of the rights offer - Friday September 14.
The rights offer is fully underwritten by Remgro‚ through its wholly-owned subsidiary Industrial Partnership Investments Proprietary Limited.
Mediclinic said on Friday that all conditions precedent pertaining to the rights offer have been fulfilled.
*Follow Fin24 on Twitter, Facebook and Google+.
The rights offer will consist of an offer of 174 641 984 new Mediclinic shares at an issue price of R28.63 per share in the ratio of 26.77263 new Mediclinic shares for every 100 held on the record date of the rights offer - Friday September 14.
The rights offer is fully underwritten by Remgro‚ through its wholly-owned subsidiary Industrial Partnership Investments Proprietary Limited.
Mediclinic said on Friday that all conditions precedent pertaining to the rights offer have been fulfilled.
*Follow Fin24 on Twitter, Facebook and Google+.